Molecules and Cells

, Volume 35, Issue 3, pp 226–234 | Cite as

S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells

  • Chae Hwa Kwon
  • Hyun Jung Moon
  • Hye Ji Park
  • Jin Hwa Choi
  • Do Youn Park
Research Article

Abstract

S100A8 and S100A9 (S100A8/A9) are low-molecular weight members of the S100 family of calcium-binding proteins. Recent studies have reported S100A8/A9 promote tumorigenesis. We have previously reported that S100A8/A9 is mostly expressed in stromal cells and inflammatory cells between gastric tumor cells. However, the role of environmental S100A8/A9 in gastric cancer has not been defined. We observed in the present study the effect of S100A8/A9 on migration and invasion of gastric cancer cells. S100A8/ A9 treatment increased migration and invasionat lower concentrations that did not affect cell proliferation and cell viability. S100A8/A9 caused activation of p38 mitogenactivated protein kinase (MAPK) and nuclear factor-κB (NF-κB). The phosphorylation of p38 MAPK was not affected by the NF-κB inhibitor Bay whereas activation of NF-κB was blocked by p38 MAPK inhibitor SB203580, indicating that S100A8/A9-induced NF-κB activation is mediated by phosphorylation of p38 MAPK. S100A8/A9-induced cell migration and invasion was inhibited by SB203580 and Bay, suggesting that activation of p38 MAPK and NF-κB is involved in the S100A8/A9 induced cell migration and invasion. S100A8/A9 caused an increase in matrix metalloproteinase 2 (MMP2) and MMP12 expression, which were inhibited by SB203580 and Bay. S100A8/A9-induced cell migration and invasion was inhibited by MMP2 siRNA and MMP12 siRNA, indicating that MMP2 and MMP12 is related to the S100A8/A9 induced cell migration and invasion. Taken together, these results suggest that S100A8/A9 promotes cell migration and invasion through p38 MAPKdependent NF-κB activation leading to an increase of MMP2 and MMP12 in gastric cancer.

Keywords

gastric cancer cells MMP NF-κB p38MAPK S100A8/A9 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aggarwal, B.B. (2004). Nuclear factor-kappaB: the enemy within. Cancer Cell 6, 203–208.PubMedCrossRefGoogle Scholar
  2. Ang, C.W., Nedijadi, T.A., Sheikh, A.M., Tweedle, E., Tonack, S., Honap, S.E., Jenkins, R., Park, B.K., Schwarte-Waldhoff, I., Khattak, I., et al. (2010). Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells. Carcinogenesis 31, 1541–1551.PubMedCrossRefGoogle Scholar
  3. Choi, J.H., Shin, N.R., Moon, H.J., Kwon, C.H., Kim, G.H., Song, G.A., Jeon, T.Y., Kim, D.H., and Park, D.Y. (2012). Identification of S100A8 and S100A9 as negative regulators for lymph node metastasis of gastric adenocarcinoma. Histol. Histopathol. 27, 1439–1448.PubMedGoogle Scholar
  4. Dong, W., Li, H., Zhang, Y., Yang, H., Guo, M., Li, L., and Liu, T. (2011). Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer. Acta Biochim. Biophys. Sin. 43, 840–848.PubMedCrossRefGoogle Scholar
  5. Egeblad, M., and Werb, Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161–174.PubMedCrossRefGoogle Scholar
  6. Foell, D., Wittkowski, H., Vogl, T., and Roth, J. (2007). S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81, 28–37.PubMedCrossRefGoogle Scholar
  7. Gebhardt, C., Nemeth, J., Angel, P., and Hess, J. (2006). S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 72, 1622–1631.PubMedCrossRefGoogle Scholar
  8. Gebhardt, C., Riehl, A., Durchdewald, M., Nemeth, J., Furstenberger, G., Muller-Decker, K., Enk, A., Arnold, B., Bierhaus, A., Nawroth, P.P., et al. (2008). RAGE signaling sustains inflammation and promotes tumor development. J. Exp. Med. 205, 275–285.PubMedCrossRefGoogle Scholar
  9. Ghavami, S., Kerkhoff, C., Los, M., Hashemi, M., Sorg, C., and Karami-Tehrani, F. (2004). Mechanism of apoptosis induced by S100A8/A9 in colon cancer cell lines: the role of ROS and the effect of metal ions. J. Leukoc. Biol. 76, 169–175.PubMedCrossRefGoogle Scholar
  10. Ghavami, S., Kerkhoff, C., Chazin, W.J., Kadkhoda, K., Xiao, W., Zuse, A., Hashemi, M., Eshraghi, M., Schulze-Osthoff, K., Klonisch, T., et al. (2008a). S100A8/9 induces cell death via a novel, RAGE-independent pathway that involves selective release of Smac/DIABLO and Omi/HtrA2. Biochim. Biophys. Acta. 1783, 297–311.PubMedCrossRefGoogle Scholar
  11. Ghavami, S., Rashedi, I., Dattilo, B.M., Eshraghi, M., Chazin, W.J., Hashemi, M., Wesselborg, S., Kerkhoff, C., and Los, M. (2008b). S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukocyte Biol. 83, 1484–1492.PubMedCrossRefGoogle Scholar
  12. Ghavami, S., Chitayat, S., Hashemi, M., Eshraghi, M., Chazin, W.J., Halayko, A.J., and Kerkhoff, C. (2009). S100A8/A9: a Janusfaced molecule in cancer therapy and tumorgenesis. Eur. J. Pharmacol. 625, 73–83.PubMedCrossRefGoogle Scholar
  13. Hermani, A., De Servi, B., Medunganin, S., Tessier, P.A., and Mayer, D. (2006). S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell. Res. 312, 184–197.PubMedCrossRefGoogle Scholar
  14. Hiratsuka, S., Watanabe, A., Aburantani, H., and Maru, Y. (2006). Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369–1375.PubMedCrossRefGoogle Scholar
  15. Hiratsuka, S., Watanabe, A., Sakurai, Y., Akashi-Takamura, S., Ishibashi, S., Miyake K., Shibuya, M., Akira, S., Aburatani, H., and Maru, Y. (2008). The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat. Cell Biol. 10, 1349–1355.PubMedCrossRefGoogle Scholar
  16. Hofmann, H.S., Hansen, G., Richter, G., Taege, C., Simm, A., Silber, R.E., and Burdach, S. (2005). Matrixproteinase-12 expression correlates with local recurrence and metastatic desease in non-small cell lung cancer patients. Clin. Cancer Res. 11, 1086–1092.PubMedGoogle Scholar
  17. Ichikawa, M., Williams, R., Wang, L., Vogl, T., and Srikrichna, G. (2011). S100A8/A9 acrivate key genes and pathways in colon tumor progression. Mol. Cancer Res. 9, 133–148.PubMedCrossRefGoogle Scholar
  18. Joyce, J.A., and Pollard, J.W. (2009). Microenvironmental regulation of metastasis. Nat. Rev. Cancer 9, 239–252.PubMedCrossRefGoogle Scholar
  19. Kerkela, E., Ala-aho, R., Klemi, P., Grenman, S., Shapiro, S.D., Kahari, V.M., and Saarialho-Kere, U. (2002). Metalloelastease (MMP-12) expression by tumour squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J. Pathol. 198, 258–269.PubMedCrossRefGoogle Scholar
  20. Li, J., Lau, G.K., Chen, L., Dong, S.S., Lan, H.Y., Huang, X.R., Li, Y., Luk, J.M., Yuan, Y.F., and Guan, X.Y. (2011). Interlukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One 6, e21816.PubMedCrossRefGoogle Scholar
  21. Moon, A., Yong, H.Y., Song, J.I., Cukovic, D., Salagrama, S., Kaplan, D., Putt, D., Kim, H., Dombkowski, A., and Kim, H.R. (2008). Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol. Cancer Res. 6, 1544–1553.PubMedCrossRefGoogle Scholar
  22. Nacken, W., and Kerkhoff, C. (2007). The hetero-oligomeric complex of the S100A8/A9 protein is extremely protease resistant. FEBS Lett. 581, 5127–5130.PubMedCrossRefGoogle Scholar
  23. Nacken, W., Roth, J., Sorg, C., and Kerkhoff, C. (2003). S100A9/S100A8: Myeloid representative of the S100 protein family ac prominent players in innate immunity. Microsc. Res. Tech. 60, 569–580.PubMedCrossRefGoogle Scholar
  24. Ng, K.T., Qi, X., Kong, K.L., Cheung, B.Y., Lo, C.M., Poon, R.T., Fan, S.T., and Man, K. (2011). Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma. Eur. J. Cancer 47, 2299–2305.PubMedCrossRefGoogle Scholar
  25. Rao, J.S. (2003). Molecular mechanisms of glioma invasiveness: the role of proteases. Nat. Rev. Cancer 3, 489–501.PubMedCrossRefGoogle Scholar
  26. Roth, J., Goebeler, M., and Sorg, C. (2001). S100A8 and S100A9 in inflammatory diseases. Lancet 257, 1041.CrossRefGoogle Scholar
  27. Roth, J., Vogl, T., Sorg, C., and Sunderkötter, C. (2003). Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol. 24, 155–158.PubMedCrossRefGoogle Scholar
  28. Roy, R., Yang, J., and Moses, M.A. (2009). Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J. Clin. Oncol. 27, 5287–5297.PubMedCrossRefGoogle Scholar
  29. Rychman, C., Vandal, K., Rouleau, P., Talbot, M., and Tessier, P.A. (2003). Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutophilchemotaxis and adhesion. J. Immunol. 170, 3233–3242.Google Scholar
  30. Salama, I., Malone, P.S., Mihaimeed, F., and Jones, J.L. (2008). A review of the S100 proteins in cancer. Eur. J. Surg. Oncol. 34, 357–364.PubMedCrossRefGoogle Scholar
  31. Sheikh, A.A., Vimalachandran, D., Thompson, C.C., Jenkins, R.E., Nedjadi, T., Shekouh, A., Campbell, F., Dodson, A., Prime, W., Crnogorac-Jurcevic, T., et al. (2007). The expression of S100A8 in pancreatic cancer-associated monocyte is associated with the Smad4 status of pancreatic cancer cells. Proteomics 7, 1929–1940.PubMedCrossRefGoogle Scholar
  32. Silva, D. (2004). Signaling pathways responsible for cancer cell invasion as targets for cancer therapy. Curr. Cancer Drug Targets 4, 327–336.CrossRefGoogle Scholar
  33. Smith, M.G., Hold, G.L., Tahara, E., and El-Omar, E.M. (2006). Cellular and molecular aspects of gastric cancer. World J. Gastroenterol. 12, 2979–2990.PubMedGoogle Scholar
  34. Takada, Y., Singh, S., and Aggarwal, B.B. (2004). Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in downregulation of NF-kappaB-mediated gene expression and upregulation of apoptosis. J. Biol. Chem. 279, 15096–15104.PubMedCrossRefGoogle Scholar
  35. Turovskaya, O., Foell, D., Shiha, P., Vogl, T., Newlin, R., Nayak, J., Nguyen, M., Olsson, A., Nawroth, P.P., Bierhus, A., et al. (2008). RAGE, carboxylatedglycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 29, 2035–2043.PubMedCrossRefGoogle Scholar
  36. Whiteside, T.L. (2008). The tumor microenvironment and its role in promoting tumor growth. Oncogene 27, 5904–5912.PubMedCrossRefGoogle Scholar
  37. Yong, H.Y., and Moon, A. (2007). Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch. Pharm. Res. 30, 75–81.PubMedCrossRefGoogle Scholar
  38. Zhao, Z.S., Wang, Y.Y., Chu, Y.Q., Ye, Z.Y., and Tao, H.Q. (2010). SPARC is associated with gastric cancer progression and poor survival of patients. Clin. Cancer Res. 16, 260–268.PubMedCrossRefGoogle Scholar

Copyright information

© The Korean Society for Molecular and Cellular Biology and Springer Netherlands 2013

Authors and Affiliations

  • Chae Hwa Kwon
    • 1
    • 2
    • 3
  • Hyun Jung Moon
    • 1
    • 2
  • Hye Ji Park
    • 1
    • 2
  • Jin Hwa Choi
    • 1
  • Do Youn Park
    • 1
    • 2
    • 3
  1. 1.Department of PathologyPusan National University Hospital and Pusan National University School of MedicineBusanKorea
  2. 2.Cancer Research InstitutePusan National University Hospital and Pusan National University School of MedicineBusanKorea
  3. 3.Biomedical Research InstitutePusan National University HospitalBusanKorea

Personalised recommendations